|Articles|October 1, 2017
- Pharmaceutical Executive-10-01-2017
- Volume 37
- Issue 10
Pharmaceutical Executive, October 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Pharm Exec's Emerging Pharma Leaders 2017about 8 years ago
How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’about 8 years ago
Glimmers of Hope for Innovation Support in Europeabout 8 years ago
The Future of Real-World Studiesabout 8 years ago
Inspiring People, Inspiring Teamsabout 8 years ago
Country Report: ColombiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
